Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Cash from Discontinued Operations (2023 - 2025)

Legend Biotech filings provide 3 years of Cash from Discontinued Operations readings, the most recent being 106286000.0 for Q1 2025.

  • On a quarterly basis, Cash from Discontinued Operations fell 4558.31% to 106286000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was 281625000.0, a N/A change, with the full-year FY2024 number at 144033000.0, up 63.38% from a year prior.
  • Cash from Discontinued Operations hit 106286000.0 in Q1 2025 for Legend Biotech, down from 82078000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 2384000.0 in Q1 2024 to a low of 106286000.0 in Q1 2025.
  • Median Cash from Discontinued Operations over the past 3 years was 88861500.0 (2023), compared with a mean of 70406250.0.
  • Biggest five-year swings in Cash from Discontinued Operations: increased 14.18% in 2024 and later tumbled 4558.31% in 2025.
  • Legend Biotech's Cash from Discontinued Operations stood at 95645000.0 in 2023, then grew by 14.18% to 82078000.0 in 2024, then fell by 29.49% to 106286000.0 in 2025.
  • The last three reported values for Cash from Discontinued Operations were 106286000.0 (Q1 2025), 82078000.0 (Q4 2024), and 2384000.0 (Q1 2024) per Business Quant data.